Join us at the Annual Biologics Symposium to discuss the latest advances in the biologics field
The Annual Biologics Symposium is back for its eighth year, and we're confident that 2018 is going to be our most inspiring year yet!
This two day educational event brings together peers from across the biologics community to share information and discuss real life research, techniques and challenges in biological drug development.
We are delighted to have the following speakers confirmed for the symposium:
Dr. Armin Sepp - Systems Modeling and Translational Biology, GSK
Predictive Physiologically-Based Pharmacokinetics (PBPK) for Biologics
Dr. Tomáš Hanke - Professor in Vaccine Immunology, University of Oxford
HIV-1 Vaccines: Dealing with Diversity
Dr. Richard Sainson - Director in Pharmacology and Translational Sciences, Kymab Ltd
KY1044, a novel anti-ICOS antibody, elicits long term in vivo anti-tumour efficacy as monotherapy or in combination with immune checkpoint inhibitors
Dr. Katja Fiedler - Scientist, CureVac
Intratumoral RNA therapy for solid tumors
Dr. Mark Aspinall-O'Dea - EMEA Business Development Manager, Retrogenix Ltd
Identifying critical target receptors and assessing specificity of biologics using cell microarray technology
Dr. Rocky Cranenburgh - Chief Scientific Officer, Prokarium Ltd
The Vaxonella platform for oral vaccine delivery using Salmonella
Dr. Anne Goubier - VP Immunology, Tusk Therapeutics
Targeting CD38 beyond haematological malignancies: a panel of anti-CD38 antibodies with unique functional properties
Vasanthi Mowat - Director of Pathology, Envigo
Interpreting histopathology challenges with biologics: background, immune-mediated or pharmacology?
Dr. Jonathan Hare - Senior Manager, Vaccine Design & Development, IAVI
How understanding the host-pathogen relationship can contribute to rationale HIV CD-8 T-cell vaccine design (and beyond)
Dr. Fiona Sewell - Programme Manager in Toxicology and Regulatory Sciences, NC3Rs
Are we fully exploiting the use of a single species for post-‘First-in-Human’ (FIH) studies allowed within ICHS6?
Dr Keith Martin - CEO, Apitope
Apitopes® to treat the cause of autoimmune diseases: from concept to clinic
Dr. Neil Williams - Chief Scientific Officer/Founder, KWS BioTest
Building a translational pathway in immune oncology: from cell biology to PD to efficacy and biomarker design
Dr. Julie Tordo - Senior Non-clinical Study Manager, Cell and Gene Therapy Catapult
Challenges and safety considerations for Gene-based Therapies
100% of delegates from our past three annual events have said they would attend again, so what are you waiting for? Register today to secure your seat!
We’re delighted to be hosting the 2018 event at the IET London: Savoy Place, which has recently undergone a £30 million refurbishment. Located on the River Thames, we’re confident that this inspiring venue will help make the eighth Annual Biologics Symposium one to remember. Click here to explore the venue.
Monday 1 October, 2018, 17:00 - 18:00 (straight after the closing remarks)
A chance to get together with fellow delegates and speakers to continue discussions and make new connections. Nibbles and drinks will be served in the Maxwell Library at the IET London: Savoy Place.
Questions, comments or suggestions?
Please get in touch, we'd love to hear from you. Our friendly events team can be reached via email: [email protected] or via phone +44 (0)1480 892038.
We look forward to meeting you in London!
Monday, October 01st 2018
09:00 – 17:00 (GMT)
IET London: Savoy Place, 2 Savoy Place, London, WC2R 0BL